|
2025 Journal Article Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID TrialEzekowitz, Justin A., Mulder, Hillary, Mentz, Robert J., Butler, Javed, De Pasquale, Carmine G., Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Adamczyk, Robert, Numan, Syed, Blackman, Nicole, Rockhold, Frank W. and Hernandez, Adrian F. (2025). Prediction and Longer-Term Outcomes of All-cause and Cardiovascular Mortality in the HEART-FID Trial. Journal of Cardiac Failure. doi: 10.1016/j.cardfail.2025.01.009 |
|
2024 Conference Publication Resting Left Atrial Reservoir Stain—A Single Parameter to Exclude HFpEFTomlinson, S., Savage, M., Edwards, N., McKenzie, S., Wong, Y., Dashwood, A., Chamberlain, R., Loy, J., Grisanti, C., Scalia, G. and Chan, W. (2024). Resting Left Atrial Reservoir Stain—A Single Parameter to Exclude HFpEF. 72nd Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Perth, WA Australia, 1-4 August 2024. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2024.06.186 |
|
2024 Conference Publication Serum phosphate levels over time with intravenous ferric carboxymaltose as treatment for heart failure with reduction ejection fraction and iron deficiency: a prospective substudy from heart-FIDNouhravesh, Nina, Garg, Jyotsna, Rockhold, Frank, De Pasquale, Carmine, O'Meara, Eileen, Lewis, Gregory D., Butler, Javed, Harrington, Josephine, Ezekowitz, Justin A., Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Blackman, Nicole, Numan, Syed, Adamczyk, Robert, Hernandez, Adrian F. and Mentz, Robert John (2024). Serum phosphate levels over time with intravenous ferric carboxymaltose as treatment for heart failure with reduction ejection fraction and iron deficiency: a prospective substudy from heart-FID. ACC.24, Atlanta, GA, United States, 6-8 April 2024. San Diego, CA, United States: Elsevier. doi: 10.1016/s0735-1097(24)02373-8 |
|
2024 Conference Publication All-cause Mortality In The HEART-FID TrialEzekowitz, Justin A., Mulder, Hillary, Mentz, Robert John, Butler, Javed, De Pasquale, Carmine, Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Blackman, Nicole, Numan, Syed, Rockhold, Frank and Hernandez, Adrian F. (2024). All-cause Mortality In The HEART-FID Trial. ACC.24, Atlanta, GA United States, 6-8 April 2024. San Diego, CA United States: Elsevier. doi: 10.1016/s0735-1097(24)02481-1 |
|
2024 Conference Publication Functional And Hematological Implications Of Distinct Definitions Of Iron Deficiency In Heart Failure: A Substudy From The HEART-FID TrialLewis, Gregory D., Giczewska, Anna, Mentz, Robert John, Butler, Javed, Ezekowitz, Justin A., O'Meara, Eileen, Troughton, Richard W., Ponikowski, Piotr, Wong, Yee Weng, Malhotra, Rajeev, Blackman, Nicole, Rockhold, Frank and Hernandez, Adrian F. (2024). Functional And Hematological Implications Of Distinct Definitions Of Iron Deficiency In Heart Failure: A Substudy From The HEART-FID Trial. ACC.24, Atlanta, GA United States, 6-8 April 2024. San Diego, CA United States: Elsevier. doi: 10.1016/s0735-1097(24)02372-6 |
|
2024 Journal Article Hierarchical end points in prior heart failure trials and the HEART-FID TrialHarrington, Josephine, Mentz, Robert J., Rockhold, Frank W., Garg, Jyotsna, Butler, Javed, De Pasquale, Carmine G., Ezekowitz, Justin A., Lewis, Gregory D., O’Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee W., Adamczyk, Robert, Storie, Tatyana, Blackman, Nicole and Hernandez, Adrian F. (2024). Hierarchical end points in prior heart failure trials and the HEART-FID Trial. Circulation: Heart Failure, 17 (2) e010676, 169-177. doi: 10.1161/circheartfailure.123.010676 |
|
2024 Book Chapter Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disordersWong, Yee Weng, Haqqani, Haris and Molenaar, Peter (2024). Roles of β-adrenoceptor subtypes and therapeutics in human cardiovascular disease: heart failure, tachyarrhythmias and other cardiovascular disorders. Adrenoceptors. (pp. 1-49) edited by Jillian G. Baker, Martin C. Michel and Roger J. Summers. Berlin, Heidelberg: Springer Berlin Heidelberg. doi: 10.1007/164_2024_720 |
|
2024 Journal Article Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FIDNouhravesh, Nina, Garg, Jyotsna, Rockhold, Frank W., De Pasquale, Carmine G., O'Meara, Eileen, Lewis, Gregory D., Butler, Javed, Harrington, Josephine, Ezekowitz, Justin A., Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Blackman, Nicole, Numan, Syed, Adamczyk, Robert, Hernandez, Adrian F. and Mentz, Robert J. (2024). Characterization of serum phosphate levels over time with intravenous ferric carboxymaltose versus placebo as treatment for heart failure with reduced ejection fraction and iron deficiency: An exploratory prospective substudy from HEART-FID. European Journal of Heart Failure. doi: 10.1002/ejhf.3348 |
|
2023 Journal Article Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trialHarrington, Josephine, Mentz, Robert J., Rockhold, Frank W., Garg, Jyotsna, Butler, Javed, De Pasquale, Carmine G., Ezekowitz, Justin A., Lewis, Gregory D., O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W., Wong, Yee Weng, Adamczyk, Robert, Blackman, Nicole and Hernandez, Adrian F. (2023). Baseline characteristics of patients in the randomized study to investigate the efficacy and safety of ferric carboxymaltose as treatment for heart failure with iron deficiency: HEART-FID trial. American Heart Journal, 266, 25-31. doi: 10.1016/j.ahj.2023.08.005 |
|
2023 Journal Article ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictorsKhoo, John King, Trewin, Benjamin P., Adji, Audrey, Wong, Yee Weng and Hungerford, Sara (2023). ST elevation myocardial infarction complicated by cardiogenic shock: Systematic review of survival predictors. American Journal of Medicine Open, 10 100057, 1-8. doi: 10.1016/j.ajmo.2023.100057 |
|
2023 Journal Article Ferric Carboxymaltose in Heart Failure with Iron DeficiencyMentz, Robert J, Garg, Jyotsna, Rockhold, Frank W, Butler, Javed, De Pasquale, Carmine G, Ezekowitz, Justin A, Lewis, Gregory D, O'Meara, Eileen, Ponikowski, Piotr, Troughton, Richard W, Wong, Yee Weng, She, Lilin, Harrington, Josephine, Adamczyk, Robert, Blackman, Nicole, Hernandez, Adrian F and for the HEART-FID Investigators (2023). Ferric Carboxymaltose in Heart Failure with Iron Deficiency. The New England Journal of Medicine, 389 (11), 975-986. doi: 10.1056/NEJMoa2304968 |
|
2023 Journal Article Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic CardiomyopathyBois, John P., Ayoub, Chadi, Geske, Jeffrey B., Wong, Yee Weng, Abbasi, Muhannad A., Foley, Thomas A., Mulvagh, Sharon L., Scott, Christopher G., Ommen, Steve R. and Pellikka, Patricia A. (2023). Ultrasound Enhancing Agents with Transthoracic Echocardiography for Maximal Wall Thickness in Hypertrophic Cardiomyopathy. Mayo Clinic Proceedings: Innovations, Quality & Outcomes, 7 (4), 309-319. doi: 10.1016/j.mayocpiqo.2023.06.002 |
|
2023 Conference Publication Clinical Trial Investigator and Patient Gender Concordance: Participation Bias?Wattchow, N., Chan, A., Amerena, J., Atherton, J., Cross, D., Dwyer, N., Kumarasinghe, G., Lam, K., McKenzie, S., Stokes, M., Sverdlov, A., Wong, Y. and De Pasquale, C. (2023). Clinical Trial Investigator and Patient Gender Concordance: Participation Bias?. 71st Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Adelaide, SA Australia, 3-6 August 2023. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2023.06.056 |
|
2022 Journal Article Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome studyChamberlain, Robert, Edwards, Natalie F. A., Doyle, Samantha N., Wong, Yee Weng, Scalia, Gregory M., Sabapathy, Surendran and Chan, Jonathan (2022). Prognostic Value of Left and right ventricular deformation strain analysis on Acute Cellular rejection in Heart Transplant recipients: A 6-year outcome study. International Journal of Cardiovascular Imaging, 38 (11), 2271-2281. doi: 10.1007/s10554-022-02586-z |
|
2022 Conference Publication Embedding Genetic Counselling Into Cardiology Clinics: Case Studies From a Queensland Cardiology Genomics ServiceRutstein, A., Baldini, M., Morris, N., Atherton, J., McCormack, L., Wong, Y., Dashwood, A., Wee, Y., McKenzie, S., Wang, W., Hill, J., Denman, R., Ng, K. and Haqqani, H. (2022). Embedding Genetic Counselling Into Cardiology Clinics: Case Studies From a Queensland Cardiology Genomics Service. International Clinical Cardiovascular Genetics Meeting, Brisbane, QLD Australia, 12-13 May 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.04.039 |
|
2022 Conference Publication Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing VentricleSpratt, M., Dashwood, A., Cheesman, E., Haqqani, H., Wong, Y., Chan, W., Laver, D. and Molenaar, P. (2022). Antiarrhythmic Effects of Phenytoin, a Novel Heart Failure Diastolic Ryanodine Channel Inhibitor, in Human Failing Ventricle. 70th Annual Scientific Meeting of the Cardiac Society of Australia and New Zealand, Gold Coast, QLD Australia, 11-14 August 2022. Chatswood, NSW Australia: Elsevier. doi: 10.1016/j.hlc.2022.06.062 |
|
2021 Journal Article Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartanGan, Jaclyn, Rheault, Haunnah and Wong, Yee Weng (2021). Who ‘nose’, is it the angiotensin receptor neprilysin inhibitor?: a case series of persistent nasal pruritus in heart failure patients receiving sacubitril/valsartan. European Heart Journal - Case Reports, 5 (12) ytab506, ytab506. doi: 10.1093/ehjcr/ytab506 |
|
2021 Journal Article Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and designMentz, Robert J., Ambrosy, Andrew P., Ezekowitz, Justin A., Lewis, Gregory D., Butler, Javed, Wong, Yee Weng, De Pasquale, Carmine G., Troughton, Richard W., O’Meara, Eileen, Rockhold, Frank W., Garg, Jyostna, Samsky, Marc D., Leloudis, Dianne, Dugan, Michael, Mundy, Linda M., Hernandez, Adrian F. and on behalf of the HEART-FID Trial Investigators (2021). Randomized placebo-controlled trial of ferric carboxymaltose in heart failure with iron deficiency: rationale and design. Circulation: Heart Failure, 14 (5) e008100, 596-603. doi: 10.1161/circheartfailure.120.008100 |
|
2021 Journal Article Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenalineDashwood, Alexander, Cheesman, Elizabeth, Wong, Yee Weng, Haqqani, Haris, Beard, Nicole, Hay, Karen, Spratt, Melanie, Chan, Wandy and Molenaar, Peter (2021). Effects of omecamtiv mecarbil on failing human ventricular trabeculae and interaction with (−)‐noradrenaline. Pharmacology Research and Perspectives, 9 (3) e00760, e00760. doi: 10.1002/prp2.760 |
|
2021 Conference Publication Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk FactorsWong, Y., Maddicks-Law, J., Raymond, P., Davidson, M., Thomson, B., Sharma, V., Javorsky, G. and Prabhu, A. (2021). Real World Experience with Transmedics Organ Care System in Cardiac Transplantation with Donor Organs Associated with Marginal Risk Factors. ISHLT2021 41st Annual Meeting & Scientific Sessions, Online, 24-28 April 2021. Philadelphia, PA United States: Elsevier. doi: 10.1016/j.healun.2021.01.569 |
